The Effect of Growth Factor on Implant Osseointegration
Bone Loss, Alveolar, Resorption, Bone, Osseointegration Failure of Dental Implant
About this trial
This is an interventional treatment trial for Bone Loss, Alveolar focused on measuring Advanced Platelet Rich Fibrin, Concentrated Growth Factor, Implant Osseointegration, Resonance Frequency Analysis
Eligibility Criteria
Inclusion Criteria:
- - Having no systemic disorder,
- Not being pregnant or breastfeeding,
- Having no smoking habit,
- Lack of continuous drug use due to chronic disease,
- No infection in the implant site and adjacent teeth,
- No previous implant or any augmentation procedure in the implant site,
- Adequate bone height and thickness of the implant site,
- The patient's acceptance and signing the informed consent form specific to our study describing the aim, duration, advantages and possible complications of the study.
Among the inclusion criteria in the study, no distinction was made between men and women, and the patients without these criteria were not included in the study.
Sites / Locations
- Ugur Can Unlugenc
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
A-PRF Test Group
CGF Test Group
A-PRF Control Group
CGF Control Group
Advanced Platelet Rich Fibrin liquid applied into the implant cavity and implant surface. That is the only difference between A-PRF control group and A-PRF test group.
Concentrated growth factor liquid applied into the implant cavity and implant surface. That is the only difference between CGF control group and CGF test group.
Dental implant applications were made with traditional methods.
Dental implant applications were made with traditional methods.